Catherine Welsh

Associate Professor of Clinical

Medicine

Phone305-243-6604
Emailcwelsh@med.miami.edu

721 Citations

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Catherine Welsh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

ADP-Ribosylation Factors Medicine & Life Sciences

docetaxel Medicine & Life Sciences

Guanine Nucleotides Medicine & Life Sciences

Guanosine Triphosphate Medicine & Life Sciences

Cyclin D1 Medicine & Life Sciences

Breast Neoplasms Medicine & Life Sciences

Cholera Toxin Medicine & Life Sciences

rho GTP-Binding Proteins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2001 2006

1 Finished

Rho GtPase and Cell Cycle Regulation in Breast Cancer

Welsh, C.

National Institutes of Health

9/1/01 → 8/31/06

Project: Research project

rho GTP-Binding Proteins

Cell Cycle

Breast Neoplasms

Cyclin D1

Epithelial Cells

Research Output 1992 2017

721 Citations
18 Article
1 Review article

2 Citations (Scopus)

A Breast Cancer Review: Through the Eyes of the Doctor, Nurse, and Patient

Klevos, G., Ezuddin, N. S., Vinyard, A., Ghaddar, T., Gort, T., Almuna, A., Abisch, A. & Welsh, C., Sep 1 2017, In : Journal of Radiology Nursing. 36, 3, p. 158-165 8 p.

Research output: Contribution to journal › Review article

Nurses

Breast Neoplasms

Breast

Psychology

Physicians

49 Citations (Scopus)

Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer

Montero, A. J., Diaz-Montero, C. M., Deutsch, Y. E., Hurley, J., Koniaris, L. G., Rumboldt, T., Yasir, S., Jorda, M., Garret-Mayer, E., Avisar, E., Slingerland, J. M., Silva, O., Welsh, C., Schuhwerk, K., Seo, P. H., Pegram, M. D. & Glück, S., Feb 1 2012, In : Breast Cancer Research and Treatment. 132, 1, p. 215-223 9 p.

Research output: Contribution to journal › Article

docetaxel

Neoadjuvant Therapy

Doxorubicin

Cyclophosphamide

Breast Neoplasms

53 Citations (Scopus)

Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer

Lobo, C., Lopes, G., Baez, O., Castrellon, A., Ferrell, A., Higgins, C., Hurley, E., Hurley, J., Reis, I., Richman, S. P., Seo, P. H., Silva, O., Slingerland, J. M., Tukia, K., Welsh, C. & Glück, S., Sep 1 2010, In : Breast Cancer Research and Treatment. 123, 2, p. 427-435 9 p.

Research output: Contribution to journal › Article

gemcitabine

Breast Neoplasms

Disease-Free Survival

Nanoparticles

Therapeutics

Erratum: Timing of cyclin D1 expression within G1 phase is controlled by Rho (Nature Cell Biology (2001) 3 (950-957))

Welsh, C., Roovers, K., Villanueva, J., Liu, Y., Schwartz, M. A. & Assoian, R. K., Dec 1 2009, In : Nature Cell Biology. 11, 12

Research output: Contribution to journal › Article

Cyclin D1

G1 Phase

Cell Biology

11 Citations (Scopus)

A phase II trial of split, low-dose docetaxel and low-dose capecitabine: A tolerable and efficacious regimen in the first-line treatment of patients with HER2/neu-negative metastatic breast cancer

Silva, O., Lopes, G., Morgenzstern, D., Lobo, C., Doliny, P., Santos, E., Abdullah, S., Gautam, U., Reis, I., Welsh, C., Slingerland, J. M., Hurley, J. & Gluck, S., Jan 1 2008, In : Clinical Breast Cancer. 8, 2, p. 162-167 6 p.

Research output: Contribution to journal › Article

docetaxel

Breast Neoplasms

Therapeutics

Appointments and Schedules

Capecitabine